Back

RNA-based inhibitors to correct dyslipidemia.

26 August 2018 (15:07 - 15:26)
Organised by:
Congress Presentation Part of: The promise of RNA-based therapeutics and diagnostics Genetics, Epigenetics, ncRNA ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Extracellular vesicles as RNA delivery systems: how far we are from their therapeutic or diagnostic use?
Professor P. Ferdinandy (Budapest, HU)
Slides Video
Presentation thumbnail
Light activated RNA therapeutic strategies.
Professor S. Dimmeler (Frankfurt, DE)
Presentation thumbnail
Circulating microRNAs as diagnostic biomarkers
Doctor D. De Gonzalo Calvo (Barcelona, ES)

Access the full session

Session thumbnail
The promise of RNA-based therapeutics and diagnostics

The Event

Event poster

ESC Congress 2018

26 August 2018 15:07 CET
You may be interested in
thumbnail
Congress Presentation
RNA-based therapy in dyslipidaemia
27 August 2023
thumbnail
Congress Presentation
Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11)
30 August 2020
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources